EicOsis Initiates Phase 1b Clinical Trial of EC5026
/PRNewswire/ -- EicOsis Human Health, a pharmaceutical company engaged in the development of a novel category of non-narcotic oral analgesics centered around...
Stay updated with breaking news from Williamk Schmidt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- EicOsis Human Health, a pharmaceutical company engaged in the development of a novel category of non-narcotic oral analgesics centered around...
- New patent grant further secures South Rampart's competitive position in next-generation and disruptive investigational drugs for acute pain -NE...
South Rampart Pharma Receives Year 3 of NIH Fast-Track STTR Commercialization Grant - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- South Rampart Pharma ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the...
NEW ORLEANS, Aug. 25, 2022 /PRNewswire/ -- South Rampart Pharma ('South Rampart' or the 'Company'), a clinical-stage life science company advancin...